EUVIMEDDescoperă EUVIMED
ÜbersichtsarbeitOpen access

Toward widespread use of virtual trials in medical imaging innovation and regulatory science

Ehsan Abadi, Bruno Barufaldi, Miguel Lago, Andreu Badal, Claudia Mello-Thoms, Nick Bottenus, Kristen A Wangerin, Mitchell Goldburgh, Lawrence Tarbox, Erica Beaucage-Gauvreau, Alejandro F Frangi, Andrew Maidment and 3 more

Medical Physics · 2024

DOI: 10.1002/mp.17442 ↗

At a glance

Übersichtsarbeit in Medical Physics, 2024. Written by Ehsan Abadi and 14 co-authors. Institution: Center for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Departments of Radiology and Electrical & Computer Engineering, Medic…. Major MEDLINE topics: Diagnostic Imaging. Cited 20 times so far (Crossref); 102 references. The full text is freely available in PubMed Central. Funded by: NIH HHS, NCI NIH HHS, Royal Academy of Engineering.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

The rapid advancement in the field of medical imaging presents a challenge in keeping up to date with the necessary objective evaluations and optimizations for safe and effective use in clinical settings. These evaluations are traditionally done using clinical imaging trials, which while effective, pose several limitations including high costs, ethical considerations for repetitive experiments, time constraints, and lack of ground truth. To tackle these issues, virtual trials (aka in silico trials) have emerged as a promising alternative, using computational models of human subjects and imaging devices, and observer models/analysis to carry out experiments. To facilitate the widespread use of virtual trials within the medical imaging research community, a major need is to establish a common consensus framework that all can use. Based on the ongoing efforts of an AAPM Task Group (TG387), this article provides a comprehensive overview of the requirements for establishing virtual imaging trial frameworks, paving the way toward their widespread use within the medical imaging research community. These requirements include credibility, reproducibility, and accessibility. Credibility assessment involves verification, validation, uncertainty quantification, and sensitivity analysis, ensuring the accuracy and realism of computational models. A proper credibility assessment requires a clear context of use and the questions that the study is intended to objectively answer. For reproducibility and accessibility, this article highlights the need for detailed documentation, user‐friendly software packages, and standard input/output formats. Challenges in data and software sharing, including proprietary data and inconsistent file formats, are discussed. Recommended solutions to enhance accessibility include containerized environments and data‐sharing hubs, along with following standards such as CDISC (Clinical Data Interchange Standards Consortium). By addressing challenges associated with credibility, reproducibility, and accessibility, virtual imaging trials can be positioned as a powerful and inclusive resource, advancing medical imaging innovation and regulatory science.

Subjects

MeSH terms (MEDLINE)

Diagnostic ImagingHumansClinical Trials as TopicReproducibility of ResultsInventions

Author keywords

computational phantomscredibilityimaging simulatorsin silico trialsinformaticsmedical imaging simulationsreproducibilitysimulationsvirtual imaging trials

Authors and institutions

  • Center for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Departments of Radiology and Electrical & Computer Engineering, Medical Physics Graduate Program, Duke University, Durham, North Carolina,…
  • Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Imaging, Diagnostics and Software Reliability, OSEL, CDRH, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Department of Radiology, University of Iowa, Iowa City, Iowa, USA.
  • Department of Mechanical Engineering, University of Colorado Boulder, Boulder, Colorado, USA.
  • Research and Development, Pharmaceutical Diagnostics, GE HealthCare, Marlborough, Massachusetts, USA.

Funding

  • NIH HHS
  • NCI NIH HHS
  • Royal Academy of Engineering
  • NHLBI NIH HHS
  • ERC Advanced
  • NIBIB NIH HHS
  • National Institutes of Health

Cite

APA

Abadi, E., Barufaldi, B., Lago, M., Badal, A., Mello-Thoms, C., Bottenus, N., Wangerin, K. A., Goldburgh, M., Tarbox, L., Beaucage-Gauvreau, E., Frangi, A. F., Maidment, A., Kinahan, P. E., Bosmans, H., & Samei, E. (2024). Toward widespread use of virtual trials in medical imaging innovation and regulatory science. Medical Physics. https://doi.org/10.1002/mp.17442

Vancouver

Abadi E, Barufaldi B, Lago M, Badal A, Mello-Thoms C, Bottenus N, et al. Toward widespread use of virtual trials in medical imaging innovation and regulatory science. Medical Physics. 2024. doi:10.1002/mp.17442

BibTeX
@article{Abadi2024,
  author = {Abadi, Ehsan and Barufaldi, Bruno and Lago, Miguel and Badal, Andreu and Mello-Thoms, Claudia and Bottenus, Nick and Wangerin, Kristen A and Goldburgh, Mitchell and Tarbox, Lawrence and Beaucage-Gauvreau, Erica and Frangi, Alejandro F and Maidment, Andrew and Kinahan, Paul E and Bosmans, Hilde and Samei, Ehsan},
  title = {Toward widespread use of virtual trials in medical imaging innovation and regulatory science},
  journal = {Medical Physics},
  year = {2024},
  doi = {10.1002/mp.17442}
}
Start for free →